Peptide Decoding
All stacks Stacks / Growth hormone

CJC-1295 + GHRP-6

Corrected November 12, 2026: GHRP-6 cortisol and prolactin figures

Ipamorelin exists because of what this half does wrong.

This is the original version of the standard growth hormone pairing, still sold premixed. GHRP-6 raises cortisol and produces the strongest hunger of any compound in its class. A 1998 study introduced ipamorelin as the fix for exactly those problems, and most people now buy that instead.

Reported forLean massRecoverySleepAppetite
the original gh stack  ·  cjc/ghrp-6  ·  the first-generation pair
Raises the signal
A GHRH analog telling the pituitary to make more growth hormone. The same half used in the modern pairing.
Research only
+
Fires the pulse
The first growth hormone releasing peptide discovered. Hits the ghrelin receptor hard, and everything else that receptor controls.
Research only
Why people stack these

The same two switches, with the older key.

Growth hormone reaches the blood through two doors. CJC-1295 works the GHRH receptor and GHRP-6 works the ghrelin receptor, which is the same logic behind CJC-1295 with ipamorelin.

GHRP-6 came first. It was one of the earliest growth hormone releasing peptides discovered, and the whole class that followed was built from it.[1]

Two reasons people still choose it. It is the cheapest compound in the category, and sellers describe it as the most potent growth hormone releaser of the group, though in the 1998 head-to-head it and ipamorelin released similar amounts in swine and rats.[2]

The cost is that the ghrelin receptor does several things at once, and GHRP-6 triggers all of them.

Benefits people are after

Four benefits, and how well each one holds up.

A strong growth hormone pulseWhat the pairing is bought for, and the one thing it does reliably.
Established for both compounds
More lean massThe outcome people want from the pulse.
No trial of this pairing
Appetite, for people trying to eat moreThe one case where GHRP-6's side effect is the point.
Strongest of the class, well documented
A clean hormonal profileWhat the modern pairing offers and this one does not.
Raises cortisol and prolactin

The third row is the interesting one. For most people it is a side effect, and for a few it is the reason to choose this over the alternative.

Does it work?

Three questions, answered before anything else.

Why did ipamorelin replace GHRP-6?
Selectivity. GHRP-6 raises more than growth hormone. A 1998 animal study introduced ipamorelin as the first selective compound in the class, producing growth hormone without the ACTH and cortisol rise that GHRP-6 and GHRP-2 caused.
Is GHRP-6 weaker?
No, and that is the point. The issue is what else GHRP-6 does. Sources describe GHRP-6 as the most potent growth hormone releaser of the group. One guide puts it plainly: the difference is selectivity, not potency.
Why is GHRP-6 still sold?
Price, mostly. GHRP-6 is the cheapest in the category. We track it below the price of ipamorelin per vial, and premixed blends pairing it with CJC-1295 are still listed by several vendors.
The study that replaced it

Ipamorelin was built to fix this exact compound.

In 1998 Raun and colleagues at Novo Nordisk described ipamorelin as the first selective growth hormone secretagogue.[2] Selective meant one thing: it released growth hormone and left the rest of the system alone. That work was done in swine and rats rather than people.

The comparison was run head to head against GHRP-6 and GHRP-2 across several dose levels. At doses producing equivalent growth hormone release, ipamorelin did not raise ACTH or cortisol, and that held at more than 200 times the dose needed for growth hormone release.[2]

That finding is why the modern pairing uses ipamorelin. Selectivity for growth hormone is the property the compound was named for.[2]

The class is usually described as a progression: GHRP-6, then GHRP-2, then ipamorelin. In the 1998 comparison the first two raised ACTH and cortisol and the third did not.[2] GHRP-6 sits at the least selective end, and that is why the pairings people buy today have moved on from it.

So this pairing is not a different approach from the common one. It is the previous version of it, and the thing that changed is documented.

The hunger

Twenty minutes, and the strongest in the class.

GHRP-6 is reported to produce the most pronounced appetite stimulation of any growth hormone secretagogue, with users describing intense hunger within twenty to thirty minutes of a dose. That is a community report; the animal comparison did not measure appetite.

The mechanism is not a side effect in the usual sense. The ghrelin receptor sits on neurons in the arcuate nucleus of the hypothalamus that drive feeding, and activating it switches those cells on.[3] Those neurons have been called the hunger neurons, and ghrelin itself is the hormone that rises before meals.[3]

So the hunger and the growth hormone come from the same receptor. It is not a contaminant that better manufacturing could remove.

That matters because of why people buy a growth hormone stack. Most want body composition change, and a compound that makes eating harder to control works against that. The exception is someone trying to gain weight or recovering appetite after illness, where it is the useful part rather than the cost.

Ipamorelin acts on the same receptor and was selected for releasing growth hormone without the ACTH and cortisol response; whether it spares the hunger is a community report rather than a measured result.[2] The modern pairing's page covers the rest of its record, including two failed Phase 2 trials.

The cortisol problem

A catabolic hormone, in a stack bought to build.

In the 1998 swine comparison, GHRP-6 and GHRP-2 raised ACTH and cortisol while ipamorelin did not, even at doses more than 200 times its growth hormone dose.[2] None of the three moved prolactin, FSH, LH or thyroid-stimulating hormone in that study, so the difference is the stress axis, not prolactin.

Cortisol breaks tissue down. Raising it alongside growth hormone in a stack bought for lean mass works against the stated goal. That is the clearest argument against this pairing.

One source suggests a cleaner way to study the same question: use the selective compound and add a separate cortisol intervention, rather than a non-selective one that raises both at once. That is research framing, and the logic carries over.

Anyone taking this pairing has a reason to have cortisol, prolactin and IGF-1 measured, since all three move and none of them announce themselves. That is a conversation for a doctor.

What it costs

Cheaper, and that is most of the argument for it.

GHRP-6 is the least expensive growth hormone secretagogue we track, listed below ipamorelin.[4] On a pairing where the other half is the same compound either way, that difference is the whole saving.

Premixed versions exist. We track eleven listings pairing CJC-1295 with GHRP-6, of which zero show no stock and six do not state how much of each compound they contain.[4]

One blend is worth singling out. A vendor sells sermorelin with both GHRP-2 and GHRP-6 in one vial. Those two act on the same receptor, so that product pays twice for one door and leaves the other half of the pairing to sermorelin alone.[4]

CJC-1295 no DAC
$13.74
GHRP-6
$14.00
Ipamorelin, for comparison
$9.34
Status and sport

Nothing approved, and both banned.

Neither compound has approval anywhere. Everything sold online is research chemical material with no approved label.

Both are banned by WADA at all times, in and out of competition. Growth hormone releasing factors cover CJC-1295 and growth hormone secretagogues cover GHRP-6, so a tested athlete taking this pairing has committed a violation on two counts.

GHRP-6 is a peptide with very low oral bioavailability, which is why it is injected, and the search for orally active mimics of it produced small molecules like MK-677 and, along the way, the cloning of the receptor the whole class acts on.[5][6] That page covers MK-677, where the same receptor-overlap problem appears with GHRP-2.

Anyone already taking a growth hormone compound and considering a switch has a reason to raise cortisol and prolactin with a prescriber first. Both move on this one, and neither is obvious without a test.

Common questions

What people ask about this stack

Should I use GHRP-6 or ipamorelin with CJC-1295?

Ipamorelin is the modern choice and the reason is documented. A 1998 study in swine and rats introduced it as the first selective growth hormone secretagogue, comparing it head to head with GHRP-6 and GHRP-2. At doses producing equivalent growth hormone release it did not raise ACTH or cortisol, which GHRP-6 and GHRP-2 did. GHRP-6 is cheaper and described as the more potent growth hormone releaser, so the trade is cost and potency against a clean hormonal profile.

Why does GHRP-6 make you so hungry?

GHRP-6's hunger comes from where the ghrelin receptor sits. Those neurons are in the arcuate nucleus of the hypothalamus that drive feeding, sometimes called the hunger neurons. Switching on that receptor to release growth hormone switches those cells on at the same time. Users report intense hunger within twenty to thirty minutes, the strongest effect of any compound in the class. It cannot be separated out, because the hunger and the growth hormone come from the same receptor.

Does GHRP-6 raise cortisol?

Yes. In the 1998 swine comparison GHRP-6 and GHRP-2 raised ACTH and cortisol while ipamorelin did not, even at doses more than 200 times its growth hormone dose. Prolactin did not move with any of them in that study. Cortisol breaks tissue down, so raising it in a stack bought for lean mass works against the goal.

Is GHRP-6 weaker than ipamorelin?

No. Sources describe GHRP-6 as the most potent growth hormone releaser in the class, and one guide states that the difference between them is selectivity rather than potency. In the 1998 head-to-head, GHRP-6 and ipamorelin released similar amounts of growth hormone in swine and rats; the difference was the ACTH and cortisol that came with GHRP-6.

Is there ever a reason to pick GHRP-6?

Two. It is the cheapest compound in the category, and its appetite effect is useful rather than unwanted for someone trying to gain weight or recover appetite. One research guide notes the other case: studying the multi-hormonal effects of non-selective receptor activation specifically requires a non-selective compound. For body composition, which is why most people buy a growth hormone stack, the appetite effect works against the goal.

What about blends containing GHRP-2 and GHRP-6 together?

GHRP-2 and GHRP-6 act on the same receptor, so a vial containing both pays twice for one mechanism. We track five in-stock listing pairing sermorelin with both of them, which leaves the GHRH half of the pairing to sermorelin alone while doubling up on the ghrelin side. Compare against the other stacks.

References

What this page is built on

  • 01Bowers CY, Momany FA, Reynolds GA, Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology, 1984;114(5):1537-1545. PMID 6714155. The paper that introduced GHRP-6 (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2), a synthetic hexapeptide that released growth hormone in a dose-related way in vitro and in vivo without releasing LH, FSH, TSH or prolactin.
    PEER REVIEWED STUDY, ABSTRACT READ. ANIMAL AND IN VITRO.
  • 02Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology, 1998;139(5):552-561. PMID 9849822, DOI 10.1530/eje.0.1390552. Rat pituitary cells, anaesthetised rats and conscious swine, head to head with GHRP-6 and GHRP-2. Ipamorelin released growth hormone with potency and efficacy similar to GHRP-6. In swine, GHRP-6 and GHRP-2 raised ACTH and cortisol; ipamorelin did not, even at doses more than 200 times its growth hormone ED50. None of the compounds affected FSH, LH, prolactin or TSH.
    PEER REVIEWED STUDY, ABSTRACT READ. ANIMAL MODELS, NOT HUMAN. AUTHORS WORKED FOR THE COMPANY THAT MADE IPAMORELIN.
  • 03Intranasal delivery of a ghrelin mimetic engages the brain ghrelin signaling system in mice. PMC11795113. Source for growth hormone secretagogues such as GHRP-6 activating feeding-driving neurons in the arcuate nucleus of the hypothalamus when given systemically, for those neurons being described as hunger neurons, and for circulating ghrelin rising before mealtimes in humans.
    PEER REVIEWED ANIMAL STUDY, ABSTRACT AND INTRODUCTION READ, FULL PAPER NOT READ.
  • 04Peptide Decoding vendor pricing data. Lowest in-stock single-compound listings for CJC-1295 no DAC, GHRP-6 and ipamorelin, with listing counts, computed at page load. Eleven listings pair CJC-1295 with GHRP-6, zero of them showing no stock and six stating no composition. Five in-stock listing pairs sermorelin with both GHRP-2 and GHRP-6 in a single vial.
    OWN DATA, OUR OWN DATASET, COMPUTED AT PAGE LOAD, NO EXTERNAL LINK.
  • 05Smith RG, Van der Ploeg LHT, Howard AD, Feighner SD, Cheng K, Hickey GJ, Wyvratt MJ, Fisher MH, Nargund RP, Patchett AA. Peptidomimetic regulation of growth hormone secretion. Endocrine Reviews, 1997;18(5):621-645. Full text. Review from the Merck group that built small-molecule growth hormone secretagogues, including MK-0677, by modifying GHRP-6 and screening for compounds that could be given by mouth.
    PEER REVIEWED REVIEW BY THE DEVELOPERS, INTRODUCTION READ.
  • 06Howard AD, Feighner SD, Cully DF, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science, 1996;273(5277):974-977. PMID 8688086. Cloning of the growth hormone secretagogue receptor, the G protein-coupled receptor in pituitary and hypothalamus through which GHRP-6 and the small-molecule secretagogues act, distinct from the GHRH receptor.
    PEER REVIEWED STUDY, ABSTRACT READ.
Last reviewed November 12, 2026 · No doses appear on this page by design · Nothing here is a recommendation